[A study about hepatitis C virus infection in patients with psoriasis in a Brazilian reference center]

Danilo Leite Andrade1, Maria de Fatima Paim de Oliveira, Teodoro Felipe Pereira de Souza

  • 1Universidad Federal de Bahia (UFBa), Bahia, Brasil.

Insights

Hepatitis C virus (HCV) infection is more prevalent in psoriasis patients than in the general population. Patients with psoriasis and HCV exhibited more severe skin lesions, indicating a significant association.

Area of Science:

  • Hepatology
  • Dermatology
  • Infectious Diseases

Context:

  • Hepatitis C virus (HCV) is a significant global health concern, linked to liver disease and extrahepatic manifestations.
  • Psoriasis, a chronic inflammatory skin condition, has been anecdotally associated with HCV, but requires further investigation.
  • Understanding this comorbidity is crucial for comprehensive patient management and public health strategies.

Purpose:

  • To determine the prevalence of anti-HCV antibodies (confirmed by HCV-RNA) in patients with psoriasis.
  • To assess the clinical implications of HCV infection in this cohort, including skin lesion severity and liver disease.
  • To investigate the co-occurrence of other viral infections, such as hepatitis B virus (HBV), HTLV-I/II, and HIV I/II, in psoriasis patients.

Summary:

  • A cross-sectional study in Salvador, Bahia, analyzed 140 psoriasis patients aged over 18.
  • Serological tests revealed a 7.1% anti-HCV prevalence, significantly higher than the city's general population (1.5%).
  • HCV-positive patients presented with higher Psoriasis Area and Severity Index (PASI) scores and advanced liver fibrosis (METAVIR F3/F4).

Impact:

  • The findings highlight a higher prevalence of Hepatitis C virus in psoriasis patients, suggesting a need for routine HCV screening in this population.
  • The association between HCV and more severe psoriasis indicates potential shared pathophysiological mechanisms or exacerbation of skin disease by viral infection.
  • This study underscores the importance of considering viral infections in the comprehensive care of patients with chronic inflammatory conditions like psoriasis.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...